Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS: ELOX · Delayed Price · USD
0.860
-0.101 (-10.52%)
May 1, 2024, 1:21 PM EDT - Market open
Eloxx Pharmaceuticals Stock Forecast
ELOX's stock price has decreased by -87.64% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ELOX stock has a target of 55, which predicts an increase of 6,295.35% from the current stock price of 0.86.
Analyst Consensus: Buy
* Price targets were last updated on Jul 11, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for ELOX is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $55 | Buy | Maintains | $50 → $55 | +6,295.35% | Jul 11, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 | Buy | Reiterates | $50 | +5,713.95% | Apr 6, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $160 → $60 | Buy | Maintains | $160 → $60 | +6,876.74% | May 23, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $40 → $20 | Hold | Maintains | $40 → $20 | +2,225.58% | May 9, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 17, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-7.60
from -16.65
EPS Next Year
-0.72
from -7.60
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | 182.5M |
| Avg | n/a | n/a | n/a | n/a | 177.3M |
| Low | n/a | n/a | n/a | n/a | 170.3M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -7.82 | -0.75 | -6.81 | -8.23 | 14.20 |
| Avg | -7.60 | -0.72 | -6.62 | -8.00 | 13.79 |
| Low | -7.30 | -0.70 | -6.36 | -7.68 | 13.25 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.